Key Highlights
- $95M capital raise, including $55M in equity and $40M in debt financing.
- New investor Concord Health Partners joins existing investors such as CVS Health® Ventures.
- Thyme Care’s services reduce cancer care costs by $594 per month for navigated patients.
- Expansion plans to new markets and deeper clinical value-based care investments.
- Rapid growth in partnerships, doubling oncology collaborations in six months.
Source: PR Newswire
Notable Quotes
- “Thyme Care’s ability to enhance patient outcomes and reduce the total cost of care is directly aligned with our mission at Concord to support best-in-class companies with solutions that improve quality, increase access, and reduce cost of care.” — James Olsen, Founder and Managing Partner at Concord
- “Our latest funding is a testament to the dedication and expertise of our incredible team, whose relentless efforts drive our mission to transform the cancer care experience forward.” — Robin Shah, Co-founder and CEO at Thyme Care
- “Thyme Care’s provider-focused approach is transforming care delivery and supporting alternative payment models, and we’re excited about all the ways we can leverage our strategic expertise to continue their growth.” — Vijay Patel, Managing Partner at CVS Health® Ventures
SoHC's Take
Thyme Care’s significant capital raise underscores the critical need for innovative solutions in the cancer care ecosystem, particularly as costs continue to soar. The strategic involvement of both new and existing investors, including heavyweights like CVS Health® Ventures and Concord Health Partners, highlights the confidence in Thyme Care’s approach to value-based care. By addressing the financial and logistical challenges of cancer treatment through advanced technology and provider-led interventions, Thyme Care is poised to make a substantial impact on the industry. Their expansion into new markets and the rapid growth of partnerships indicate a robust strategy for scaling their successful model, ultimately driving better patient outcomes and cost efficiencies in oncology care.
